NCT06249334

Brief Summary

This study aims to evaluate the effects of whole-body electrical stimulation (WB-EMS) in the rehabilitation of patients undergoing lung transplantation. This is a randomized clinical trial with patients from the inpatient unit of Dom Vicente Scherer Hospital of Irmandade Santa Casa de Misericórdia from Porto Alegre (ISCMPA) who will be allocated to a control group (which will receive physiotherapy from routine) or intervention group (which will receive physiotherapy from routine and WB-EMS). Interventions with WB-EMS will occur every day from the moment of extubation until hospital discharge (15 sessions per patient). Assessments will be carried out pre-lung transplantation, after extubation, during intervention protocols and at the time of hospital discharge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

December 20, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

December 18, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

November 29, 2023

Last Update Submit

December 13, 2024

Conditions

Keywords

Lung transplantationElectric stimulationRandomized Controlled Trial

Outcome Measures

Primary Outcomes (3)

  • Isometric quadriceps muscle strength.

    Isometric quadriceps muscle strength will be evaluated using a portable dynamometer.

    Time 0 (baseline) and immediately after 15 sessions (totaling a maximum of 3 weeks).

  • Lower limb muscle strength.

    Lower limb strength will be carried out using the 10-repetition sit-and-stand test (SST).

    Time 0 (baseline) and immediately after 15 sessions (totaling a maximum of 3 weeks).

  • Mortality.

    Mortality will be assessed by counting the number of deaths occurring in the study and after hospital discharge.

    Mortality will be assessed after 30 days, after 60 days and up to 1 year after lung transplantation.

Secondary Outcomes (14)

  • Safety of whole-body electrical stimulation.

    Time 0 (pre intervention), after 10 minutes and at 20 minutes from the beginning of the intervention.

  • Safety of whole-body electrical stimulation.

    Time 0 (pre intervention), after 10 minutes and at 20 minutes from the beginning of the intervention.

  • Safety of whole-body electrical stimulation.

    Time 0 (pre intervention), after 10 minutes and at 20 minutes from the beginning of the intervention.

  • Muscle pain.

    Time 0 (pre intervention), after 10 minutes and at 20 minutes from the beginning of the intervention.

  • Safety of whole-body electrical stimulation.

    Time 0 (pre intervention), after 10 minutes and at 20 minutes from the beginning of the intervention.

  • +9 more secondary outcomes

Study Arms (2)

Whole-body electrical stimulation (WB-EMS)

EXPERIMENTAL

WB-EMS will be performed with ReCare® equipment (Visuri, Minas Gerais, Brazil). Patients will perform sessions once a day, totaling a maximum of 15 sessions. In addition to the WB-EMS protocol, the patients will receive routine physiotherapy at the hospital.

Other: Whole-body electrical stimulation

Routine physical therapy

ACTIVE COMPARATOR

Patients in the control group (active comparator) will receive routine hospital physical therapy until the moment of hospital discharge. No intervention with electrical stimulation will be performed in this group.

Other: Routine physical therapy

Interventions

The protocol with whole-body electrical stimulation will begin in the intensive care unit and will be completed in the inpatient unit. To stimulate all proposed muscle groups, self-adhesive electrodes will be positioned bilaterally on the quadriceps femoris, tibialis anterior, biceps brachii and lower rectus abdominis muscles. The frequency of 75 Hz will be adopted and the intensity will be adjusted to cause visible muscle contraction. The progression of the therapy protocol will occur throughout the sessions aiming to reach 20 minutes of therapy and 80 contractions.

Also known as: Whole-body electromyostimulation
Whole-body electrical stimulation (WB-EMS)

The protocol will be based on knee and hip flexion and extension movements; hip adduction and abduction; flexion and extension of shoulders, elbows and wrists; shoulder abduction and adduction; respecting the range of each joint. Volunteers will also perform transfers from lying to sitting and standing positions. Respiratory conduct will be based on ventilation patterns, bronchial hygiene maneuvers and cough.

Routine physical therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing unilateral or bilateral lung transplantation;
  • Admitted to the intensive care unit and without invasive ventilatory support;
  • Hemodynamically stable;
  • Time less than or equal to 7 days between lung transplantation and the beginning of rehabilitation protocols.

You may not qualify if:

  • Patients with severe psychomotor agitation;
  • Recent acute myocardial infarction (24 hours) and / or uncontrolled arrhythmias;
  • Temporary transcutaneous pacemaker;
  • Stroke after lung transplantation;
  • Decompensated heart failure;
  • Uncontrolled hypertension (systolic blood pressure \> 230 mmHg and diastolic blood pressure \> 120 mmHg) or mean arterial pressure \<60 mmHg;
  • Patients who present important hemodynamic changes during training;
  • Peripheral vascular changes in the lower limbs such as untreated deep vein thrombosis;
  • In a feverish state;
  • Patients with epidermal lesions on the thighs that make it impossible to place self-adhesive electrodes for electrical stimulation;
  • Patients with acute renal failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Health Sciences of Porto Alegre

Porto Alegre, Rio Grande Do Sul (RS), 90050170, Brazil

Location

Related Publications (1)

  • Garlet AB, Plentz RDM, Righi NC, Schardong J. Whole-body electrical stimulation in patients undergoing lung transplantation in Southern Brazil: study protocol of a single-center randomized controlled trial. Trials. 2025 Dec 5;27(1):23. doi: 10.1186/s13063-025-09177-y.

Study Officials

  • Jociane Schardong, PhD

    Federal University of Health Sciences of Porto Alegre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jociane Schardong, PhD

CONTACT

Rodrigo DM Plentz, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 29, 2023

First Posted

February 8, 2024

Study Start

December 20, 2024

Primary Completion

April 1, 2025

Study Completion

August 1, 2025

Last Updated

December 18, 2024

Record last verified: 2024-02

Locations